Cours Easton Pharmaceuticals Inc. Other OTC
Actions
EAPH
US2777741057
Recherche biotechnologique et médicale
CA 2019 | 1,56 M 1,4 M | CA 2020 | - | Capitalisation | 807 k 724 k |
---|---|---|---|---|---|
Résultat net 2019 | - 0 | Résultat net 2020 | - 0 | VE / CA 2019 | 6,27 x |
Dette nette 2019 | 8,41 M 7,55 M | Dette nette 2020 | 2,48 M 2,23 M | VE / CA 2020 | - |
PER 2019 |
-4,17
x | PER 2020 |
-4,29
x | Employés | - |
Rendement 2019 * |
-
| Rendement 2020 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/06/15 |
Vince Demasi
COO | Chief Operating Officer | - | 20/06/18 |
Chief Tech/Sci/R&D Officer | - | 01/01/15 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Evan Karras
CEO | Chief Executive Officer | - | 30/06/15 |
John Guerra
SEC | Corporate Secretary | - | 31/12/13 |
Vince Demasi
COO | Chief Operating Officer | - | 20/06/18 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,51% | 122 Md | |
+20,17% | 115 Md | |
+21,22% | 26,64 Md | |
-23,15% | 19,91 Md | |
-17,47% | 16,32 Md | |
-45,95% | 15,52 Md | |
-19,33% | 15,49 Md | |
+59,95% | 14,83 Md | |
+2,57% | 13,67 Md |